USANA Health Sciences announces $40 million for share repurchase program

USANA Health Sciences, Inc. (NASDAQ: USNA) today announced that its board of directors has authorized an additional $40 million for share repurchases of its outstanding common stock.

Since 2000, when the share repurchase program was instituted, the company has repurchased approximately 10.3 million shares for $270.2 million. Importantly, the company has largely used its cash flow from operations to fund its share buyback program. Today's $40 million authorization will be in addition to the approximately $3.9 million currently available in its share repurchase plan. USANA has 15,773,894 common shares outstanding as of August 31, 2010.

Repurchases will be made in accordance with USANA's active share repurchase program in the open market, through block trades or otherwise. The number of shares to be purchased and the timing of purchases will be based on market conditions, the level of cash balances, general business opportunities, and other factors.

Source : USANA Health Sciences

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.